News | May 27, 2022
Torrent Pharma acquires four brands from Dr Reddy’s
The integration and transition of the brands are expected to be completed by June 2022.
The integration and transition of the brands are expected to be completed by June 2022.
The groundbreaking SPF technology is specifically designed and formulated to prevent sunburn or sun damage while allowing the passage of sufficient UVB light that our bodies use to naturally produce vitamin D
The new facility at Dombivli is the fifth ASG Eye Hospital in Maharashtra
The Portal BioRRAP will cater to all those seeking regulatory approval for biological research
The partnership will further strengthen Olympus leadership in the diagnosis and staging of liver disease
Phase I trial in Rwanda and South Africa aims to evaluate mRNA HIV vaccine antigen for safety and immunogenicity and strengthen regional scientific capacity
Leading pharma companies are achieving rapid, large-scale performance improvements using a multifaceted approach that realizes short-term gains & builds long-term capabilities at the same time
It is part of the company's CAD $30 million capital investment in the Aurora, Canada site
This cost-effective tool will be of immense benefit to other high burden countries as well.
Globally, cervical cancer is the fourth most common cancer among women, with approximately 30,447 new cases diagnosed in Europe in 2020
Subscribe To Our Newsletter & Stay Updated
